Latest updates for Ostx

Fresh curated links around OSTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • OS Therapies is a buy, this analyst says
  • Otovo ASA (OTOVD) Q1 2026 Earnings Call Transcript
  • Form 4 Ocular Therapeutix Inc For: 12 June

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

cantechletter.com /22 hours ago

OS Therapies is a buy, this analyst says

Roth Capital Markets analyst Adam Walsh says OS Therapies’ (OS Therapies Incorporated Stock Quote, Chart, News, Analysts, Financials NYSE:OSTX) OST-HER2 has shown enough survival b...

Read source
seekingalpha.com /1 month ago

Otovo ASA (OTOVD) Q1 2026 Earnings Call Transcript

Read source
investing.com /1 month ago

Form 4 Ocular Therapeutix Inc For: 12 June

Read source
seekingalpha.com /1 month ago

OSE Immunotherapeutics SA (ORPOF) Discussion of Tedopi Immunotherapy Pipeline and Clinical Progress Across Oncology Indi...

Read source
seekingalpha.com /1 month ago

Syntec Optics: A Reprieve From Liquidity Concerns And Index Inclusion, Maintain Buy

Read source
seekingalpha.com /3 weeks ago

XOVR: A Private-Public Crossover ETF You Need To Know

Read source
explosiveoptions.net /1 month ago

Oscar Health Inc: Chart Analysis

Chart of the Week: Oscar Health Hey, good morning everybody! We’re gonna try this one more time here. Little audio difficulty first time around. This is our chart of the week for M...

Read source
newswire.com /1 month ago

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level

Read source
seekingalpha.com /1 month ago

Outlook Therapeutics: Potential Catalysts Offering An Arbitrage Opportunity

Read source
investing.com /1 week ago

Ocular Therapeutix options trading jumps to 9,894 contracts

Read source
newswire.com /1 month ago

REX-Osprey(TM) ETH + Staking ETF (ESK) TO LIQUIDATE

Read source
crypto.news /1 month ago

OKX adds Magnificent 7 stocks and commodities to European X Perps offering

OKX has expanded its X-Perps offering in Europe with 13 new markets, adding futures linked to major U.S. technology stocks, commodities, and stock indices after reporting a 447% ri...

Read source
seekingalpha.com /1 week ago

RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript

Read source
seekingalpha.com /20 hours ago

Oxford Square Capital: Debt Over Equity

Read source
crypto.news /1 month ago

OKX’s X Layer lets users build their own crypto markets

OKX’s X Layer launched Exchange OS, letting builders deploy spot, perp, and outcome markets as a 2026 World Cup test venue arrives in June.

Read source
fool.com /1 month ago

Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding

Artivion delivers advanced cardiovascular and vascular solutions to healthcare providers worldwide through its proprietary medical devices.

Read source
investing.com /4 weeks ago

Form 4 Oncotelic Therapeutics Inc For: 17 June

Read source
ryortho.com /1 month ago

Revolutionary 3D Motion Capture Imaging Lands in U.S.

Imaging that doesn’t force patients to lie still? Now, ORA Orthopedics is changing that equation in a big way.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Ostx

seekingalpha.com

Recent coverage from public sources
Public source

crypto.news

Recent coverage from public sources
Public source

explosiveoptions.net

Recent coverage from public sources
Public source

ryortho.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

cantechletter.com

Recent coverage from public sources
Public source